title: H2O2 inhibits BCR-dependent immediate early induction of EBV genes in Burkitt's lymphoma cells.
abstract: The critical step in the Epstein-Barr virus (EBV) transition from latency to lytic replication is activation of the viral immediate early (IE) genes, BZLF1 and BRLF1. Their induction in Burkitt's lymphoma Akata cells is directly targeted by B cell receptor (BCR) signaling. On the other hand, BCR stimulation causes an outwardly directed superoxide (O(2)(*-)) burst leading to massive generation of reactive oxygen species in the cell environment. Our goal was to investigate the role of BCR-related redox changes in the IE reactivation of EBV. Production of O(2)(*-) by stimulated Akata cells was characterized using chemiluminescent dyes, lucigenin, MCLA, and coelenterazine. Expression of the EBV IE genes was analyzed by real-time PCR and Western blot assays. Catalase activity and H(2)O(2) concentration were evaluated using Amplex Red assays and by measuring light absorption at 240 nm. We show here that elevation of H(2)O(2) concentration in Akata cell suspensions inhibits the induction of the virus IE mRNA and BZLF1 protein. It was further found that Akata cells exhibit catalase-like activity that is stimulated by BCR cross-linking. The results reveal that H(2)O(2) is instrumental in the maintenance of EBV latency. Altogether they provide new evidence demonstrating the essential role of H(2)O(2) in BCR signaling.
authors.affiliation: Pharmazentrum frankfurt/ZAFES, Johann Wolfgang Goethe University, D-60590 Frankfurt, Germany. Osipova-Goldberg@med.uni-frankfurt.de
authors.forename: Helen I
authors.initials: HI
authors.lastname: Osipova-Goldberg
authors.forename: Lyudmila V
authors.initials: LV
authors.lastname: Turchanowa
authors.forename: Barbara
authors.initials: B
authors.lastname: Adler
authors.forename: Josef M
authors.initials: JM
authors.lastname: Pfeilschifter
mesh_terms: D002051:Burkitt Lymphoma / Q000235:genetics / Q000378:metabolism* / Q000821:virology; D002374:Catalase / Q000378:metabolism; D020031:Epstein-Barr Virus Infections / Q000235:genetics / Q000378:metabolism / Q000821:virology; D004854:Herpesvirus 4, Human / Q000472:pathogenicity; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology*; D017874:Immediate-Early Proteins / Q000235:genetics / Q000378:metabolism*; D016877:Oxidants / Q000494:pharmacology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011947:Receptors, Antigen, B-Cell / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013481:Superoxides / Q000378:metabolism; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D014779:Virus Replication / Q000187:drug effects
chemical_list: C068382:BRLF1 protein, Human herpesvirus 4; C063676:BZLF1 protein, Herpesvirus 4, Human; D017874:Immediate-Early Proteins; D016877:Oxidants; D012333:RNA, Messenger; D011947:Receptors, Antigen, B-Cell; D015534:Trans-Activators; D013481:Superoxides; D006861:Hydrogen Peroxide; D002374:Catalase